Evidence map›Paper›PMID 29862074›Full record

ArticlePain research and treatment2018

Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.

Mohamed Binfalah, Eman Alghawi, Eslam Shosha, Ali Alhilly, Moiz Bakhiet

4 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Pain research and treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03666663 phase4completednot on this mapstarted 2019, after this paper: background citation

UCSF Sphenopalatine Ganglion Block Study- a Randomized Double Blind Placebo Controlled Trial to Compare Nasal Anesthetics for Migraine Prevention in Adults.

TypeinterventionalSponsorUniversity of California, San FranciscoRan2019 to 2021Enrolled10ConditionsMigraineArmsLidocaine, Bupivacaine, Ropivacaine, Placebo
NCT06243874 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparison of Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine

TypeinterventionalSponsorAnkara UniversityRan2023 to 2024Enrolled40ConditionsMigraineArmsgreater occipital nerve block, transnasal sphenopalatine ganglion block
NCT06310200 phase1active not recruitingnot on this mapstarted 2025, after this paper: background citation

Involvement of the Sphenopalatine Ganglion in Cold Induced Headaches

TypeinterventionalSponsorWright State UniversityRan2025 to 2025Enrolled30ConditionsCold Induced Headache, Brain Freeze, Cold Induced Cephalgia, HeadacheArmsLidocaine Topical 4% Topical Solution, Bitrex, normal saline
NCT07116408 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Intranasal Sphenopalatine Ganglion Blockade as a Non-invasive, Opioid-sparing Treatment for Headaches Following Aneurysmal Subarachnoid Hemorrhage

TypeinterventionalSponsorWright State UniversityRan2024 to 2027Enrolled20ConditionsAneurysmal Subarachnoid Hemorrhage (aSAH), HeadacheArmsLidocaine (drug), Tx 360
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Interventional Treatment of Arterial Hypertension in The Modern Era: An Updated Review from the Young Investigator Group of the European Society of Hypertension.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mohamed BinfalahUniversity Medical Center, King Abdullah Medical City, P.O. Box 26671, Adliya, Bahrain.ORCID 0000-0001-5053-8851
Eman AlghawiMinistry of Health, Building 1228, Road 4025, 340 Juffair, Bahrain.
Eslam ShoshaMajmaah University, Academic City, Al Majmaah 15341, Saudi Arabia.
Ali AlhillyBahrain Defense Force Hospital, P.O. Box 28743, West Riffa, Bahrain.
Moiz BakhietAljawhara Center, Arabian Gulf University, P.O. Box 26671, Manama, Bahrain.ORCID 0000-0002-5148-8849
Arabian Gulf University · BHMajmaah University · SAMinistry of Health · BH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transnasal sphenopalatine ganglion block is emerging as is an attractive and effective treatment modality for acute migraine headaches, cluster headache, trigeminal neuralgia, and several other conditions. We assessed the efficacy and safety of this treatment using the Sphenocath® device. 55 patients with acute migraine headaches underwent this procedure, receiving 2 ml of 2% lidocaine in each nostril. Pain numeric rating scale (baseline, 15 minutes, 2 hours, and 24 hours) and patient global impression of change (2 hours and 24 hours after treatment) were recorded. The majority of patients became headache-free at 15 minutes, 2 hours, and 24 hours after procedure (70.9%, 78.2%, and 70.4%, resp.). The rate of headache relief (50% or more reduction in headache intensity) was 27.3% at 15 minutes, 20% at 2 hours, and 22.2% at 24 hours. The mean pain numeric rating scale decreased significantly at 15 minutes, 2 hours, and 24 hours, respectively. Most patients rated the results as very good or good. The procedure was well-tolerated with few adverse events. This treatment is emerging as an effective and safe option for management of acute migraine attacks.

Identifiers

PMID29862074
PMCPMC5971252
OpenAlexW2802847427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.